Search research articles
Contact Us
Filters
Showing results (871-880 of 1,038) with videos related to
Page
of 104
Sort By:
Journal of the American College of Emergency Physicians Open
|
June 22, 2026
Alignment of United States Emergency Medicine Programs' Pregnancy, Parental Leave, and Lactation Policies With Recent Consensus Recommendations
Laura G Shepherd, Michelle D Lall, Shivam Champaneria, et al.
Lancet (London, England)
|
January 11, 2025
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
Armin Ghobadi, Veronika Bachanova, Krish Patel, et al.
Bone Marrow Transplantation
|
December 16, 1998
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies
P V O'Donnell, R J Jones, G B Vogelsang, et al.
The Lancet. Oncology
|
April 7, 2016
Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial
Anas Younes, Jesus G Berdeja, Manish R Patel, et al.
ACS Nano
|
February 21, 2024
Sensing the Spin State of Room-Temperature Switchable Cyanometallate Frameworks with Nitrogen-Vacancy Centers in Nanodiamonds
Bradley T Flinn, Graham A Rance, William J Cull, et al.
American Journal of Hematology
|
May 26, 2016
A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL
Ian W Flinn, Panayiotis Panayiotidis, Boris Afanasyev, et al.
Leukemia & Lymphoma
|
July 16, 2011
High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas
Douglas E Gladstone, Javier Bolaños-Meade, Carol Ann Huff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 22, 2015
Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye
Richard B Thompson, Valentina Reffatto, Jacob G Bundy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2023
Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial
A S Cottereau, L Rebaud, J Trotman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 9, 2024
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial
Matthew Matasar, Nancy L Bartlett, Mazyar Shadman, et al.
Page
of 104
Search research articles
Search
Showing results (871-880 of 1,038) with videos related to
Sort By:
Page
of 104
Journal of the American College of Emergency Physicians Open
|
June 22, 2026
Alignment of United States Emergency Medicine Programs' Pregnancy, Parental Leave, and Lactation Policies With Recent Consensus Recommendations
Laura G Shepherd, Michelle D Lall, Shivam Champaneria, et al.
Lancet (London, England)
|
January 11, 2025
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
Armin Ghobadi, Veronika Bachanova, Krish Patel, et al.
Bone Marrow Transplantation
|
December 16, 1998
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies
P V O'Donnell, R J Jones, G B Vogelsang, et al.
The Lancet. Oncology
|
April 7, 2016
Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial
Anas Younes, Jesus G Berdeja, Manish R Patel, et al.
ACS Nano
|
February 21, 2024
Sensing the Spin State of Room-Temperature Switchable Cyanometallate Frameworks with Nitrogen-Vacancy Centers in Nanodiamonds
Bradley T Flinn, Graham A Rance, William J Cull, et al.
American Journal of Hematology
|
May 26, 2016
A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL
Ian W Flinn, Panayiotis Panayiotidis, Boris Afanasyev, et al.
Leukemia & Lymphoma
|
July 16, 2011
High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas
Douglas E Gladstone, Javier Bolaños-Meade, Carol Ann Huff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 22, 2015
Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye
Richard B Thompson, Valentina Reffatto, Jacob G Bundy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2023
Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial
A S Cottereau, L Rebaud, J Trotman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 9, 2024
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial
Matthew Matasar, Nancy L Bartlett, Mazyar Shadman, et al.
Page
of 104